| Organism name | Gonocaryum calleryanum | 
|---|---|
| Genus | Gonocaryum | 
| Family | Icacinaceae | 
| Kingdom | Plantae | 
| Linked NCBI taxonomy name | Gonocaryum | 
|---|---|
| Linked NCBI taxonomy ID | 85208 | 
| Linked level | genus | 
| Family in NCBI taxonomy | Cardiopteridaceae | 
|---|---|
| ID | 125017 | 
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae | 
|---|---|
| ID | 33090 | 
| Plant class | asterids | 
|---|---|
| ID | 71274 | 
| KNApSAcK ID | name | ChEMBL link | CTD link | # of proteins in ChEMBL interaction / related OMIM / related KEGG DISEASE | # of genes in CTD interaction / related diseases | KCF-S cluster | phytochemical cluster | figure | 
|---|---|---|---|---|---|---|---|---|
| C00013607   | Apigenin 7-apiofuranosyl-(1->6)-glucoside / 5,7,4'-Trihydroxyflavone 7-apiofuranosyl-(1->6)-glucoside / 7-[(6-O-D-Apio-beta-D-furanosyl-beta-D-glucopyranosyl)oxy]-5-hydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one | No. 1 | No. 15 |   | ||||
| C00019064   | Oleanolic acid / Astrantiagenin C / Virgaureagenin B / 3beta-Hydroxyolean-12-en-28-oic acid | CHEMBL56615 CHEMBL168 CHEMBL180553 CHEMBL365375 CHEMBL486382 CHEMBL1413646 CHEMBL1436454 | D009828 | 30 / 8 / 12 | 21 / 15 | No. 13 | No. 51 |   | 
| C00003737   | alpha-Amyrin / alpha-Amyrine / alpha-Amyrenol | No. 23 | No. 51 |   | ||||
| C00003749   | Lupeol / Lupenol / (+)-Lupenol | CHEMBL289191 CHEMBL459702 | C010480 | 3 / 0 / 0 | 2 / 6 | No. 23 | No. 51 |   | 
| C00048994   | Gonocaryoside E / (-)-Gonocaryoside E | No. 56 | No. 36 |   | ||||
| C00022654   | beta-Amyrin acetate | CHEMBL489760 CHEMBL1318082 | 4 / 3 / 7 | No. 177 |   | |||
| C00048974   | Erythrodiol-3-acetate | CHEMBL480306 | No. 177 |   | ||||
| C00029633   | Ursolic acid / Acetylursolic acid | CHEMBL55086 CHEMBL410525 | 4 / 2 / 2 | No. 177 |   | |||
| C00002657   | p-Formylphenol / 4-Hydroxybenzaldehyde / p-Hydroxybenzaldehyde | CHEMBL14193 | C011483 | 3 / 2 / 2 | No. 2076 |   | ||
| C00030771   | Methylparaben / p-Methoxycarbonylphenol | CHEMBL325372 | C015358 | 102 / 49 / 57 | 3 / 0 | No. 2169 |   | |
| C00048992   | Gonocaryoside A | No. 2332 |   | |||||
| C00048993   | Gonocaryoside B | No. 2332 |   | |||||
| C00029547   | 5-Hydroxymethylfuraldehyde / 5-Hydroxymethyl-2-furfural / 5-Hydroxymethyl-2-furaldehyde / 5-(Hydroxymethyl)-2-furaldehyde | CHEMBL185885 | C008046 | 4 / 3 / 3 | 2 / 5 | No. 6025 |   | 
| accession | description | class description | KNApSAcK metabolite in interactions | # of diseases (OMIM / KEGG) | 
|---|---|---|---|---|
| P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00019064 C00030771 | 0 / 3 | 
| P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00019064 C00029633 | 0 / 0 | 
| Q9UNA4 | DNA polymerase iota | Enzyme | C00019064 C00030771 | 0 / 0 | 
| P11511 | Cytochrome P450 19A1 | Cytochrome P450 19A1 | C00019064 C00029633 | 2 / 2 | 
| P04150 | Glucocorticoid receptor | NR3C1 | C00029547 C00030771 | 0 / 1 | 
| P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00019064 C00030771 | 0 / 0 | 
| P11387 | DNA topoisomerase 1 | Isomerase | C00003749 C00022654 | 0 / 0 | 
| P06746 | DNA polymerase beta | Enzyme | C00019064 C00029633 | 0 / 0 | 
| P03372 | Estrogen receptor | NR3A1 | C00030771 | 1 / 1 | 
| Q16539 | Mitogen-activated protein kinase 14 | p38 | C00030771 | 0 / 0 | 
| P08246 | Neutrophil elastase | S1A | C00030771 | 2 / 1 | 
| P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00030771 | 0 / 0 | 
| P43166 | Carbonic anhydrase 7 | Lyase | C00030771 | 0 / 0 | 
| Q06124 | Tyrosine-protein phosphatase non-receptor type 11 | Tyr | C00019064 | 4 / 2 | 
| P29466 | Caspase-1 | C14 | C00030771 | 0 / 0 | 
| P17252 | Protein kinase C alpha type | Alpha | C00030771 | 0 / 0 | 
| P27361 | Mitogen-activated protein kinase 3 | Erk | C00030771 | 0 / 0 | 
| P14780 | Matrix metalloproteinase-9 | M10A | C00030771 | 2 / 2 | 
| P24666 | Low molecular weight phosphotyrosine protein phosphatase | Tyr | C00019064 | 0 / 0 | 
| Q8TDU6 | G-protein coupled bile acid receptor 1 | Steroid-like ligand receptor | C00019064 | 0 / 0 | 
| O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | C00019064 | 0 / 0 | 
| P08047 | Transcription factor Sp1 | Unclassified protein | C00003749 | 0 / 0 | 
| P16473 | Thyrotropin receptor | Glycohormone receptor | C00029547 | 3 / 2 | 
| P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00030771 | 1 / 1 | 
| P51649 | Succinate-semialdehyde dehydrogenase, mitochondrial | Oxidoreductase | C00002657 | 1 / 1 | 
| P00918 | Carbonic anhydrase 2 | Lyase | C00030771 | 1 / 2 | 
| P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00030771 | 0 / 1 | 
| P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00030771 | 1 / 1 | 
| P25021 | Histamine H2 receptor | Histamine receptor | C00030771 | 0 / 0 | 
| P35367 | Histamine H1 receptor | Histamine receptor | C00030771 | 0 / 0 | 
| Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00030771 | 1 / 0 | 
| P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00030771 | 0 / 0 | 
| P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00030771 | 0 / 0 | 
| P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00030771 | 0 / 0 | 
| P51452 | Dual specificity protein phosphatase 3 | Ser_Thr_Tyr | C00019064 | 0 / 0 | 
| P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00030771 | 0 / 0 | 
| P06241 | Tyrosine-protein kinase Fyn | Src | C00030771 | 0 / 0 | 
| P10586 | Receptor-type tyrosine-protein phosphatase F | Receptor tyrosine-protein phosphatase | C00019064 | 0 / 0 | 
| Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00030771 | 0 / 0 | 
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00030771 | 0 / 1 | 
| P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00030771 | 1 / 8 | 
| Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00030771 | 2 / 2 | 
| P11388 | DNA topoisomerase 2-alpha | Isomerase | C00003749 | 0 / 0 | 
| P14416 | D(2) dopamine receptor | Dopamine receptor | C00030771 | 2 / 0 | 
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00030771 | 1 / 0 | 
| P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00030771 | 0 / 0 | 
| P41145 | Kappa-type opioid receptor | Opioid receptor | C00030771 | 0 / 0 | 
| Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00030771 | 0 / 0 | 
| P29274 | Adenosine receptor A2a | Adenosine receptor | C00030771 | 0 / 0 | 
| P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00030771 | 0 / 0 | 
| P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00030771 | 1 / 1 | 
| P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00030771 | 0 / 0 | 
| P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00030771 | 1 / 0 | 
| Q9ULX7 | Carbonic anhydrase 14 | Lyase | C00030771 | 0 / 0 | 
| P00352 | Retinal dehydrogenase 1 | Enzyme | C00029547 | 0 / 0 | 
| O43570 | Carbonic anhydrase 12 | Lyase | C00030771 | 1 / 2 | 
| P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00030771 | 0 / 0 | 
| P14902 | Indoleamine 2,3-dioxygenase 1 | Enzyme | C00002657 | 0 / 0 | 
| Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00019064 | 0 / 0 | 
| O75496 | Geminin | Unclassified protein | C00019064 | 0 / 0 | 
| O60656 | UDP-glucuronosyltransferase 1-9 | Enzyme | C00030771 | 0 / 0 | 
| P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00030771 | 0 / 0 | 
| P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00030771 | 0 / 0 | 
| P21917 | D(4) dopamine receptor | Dopamine receptor | C00030771 | 0 / 0 | 
| P30988 | Calcitonin receptor | Calcitonin receptor | C00030771 | 0 / 0 | 
| P35462 | D(3) dopamine receptor | Dopamine receptor | C00030771 | 1 / 0 | 
| P41143 | Delta-type opioid receptor | Opioid receptor | C00030771 | 0 / 0 | 
| Q92731 | Estrogen receptor beta | NR3A2 | C00030771 | 0 / 1 | 
| P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00030771 | 0 / 0 | 
| P15121 | Aldose reductase | Enzyme | C00019064 | 0 / 0 | 
| P25101 | Endothelin-1 receptor | Endothelin receptor | C00030771 | 0 / 0 | 
| P30411 | B2 bradykinin receptor | Bradykinin receptor | C00030771 | 0 / 0 | 
| P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00030771 | 1 / 0 | 
| P00915 | Carbonic anhydrase 1 | Lyase | C00030771 | 0 / 0 | 
| P49841 | Glycogen synthase kinase-3 beta | Gsk | C00019064 | 0 / 0 | 
| P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00030771 | 0 / 0 | 
| P08311 | Cathepsin G | S1A | C00030771 | 0 / 0 | 
| Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00030771 | 1 / 0 | 
| P03956 | Interstitial collagenase | M10A | C00030771 | 0 / 1 | 
| P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00030771 | 0 / 0 | 
| P83916 | Chromobox protein homolog 1 | Unclassified protein | C00019064 | 0 / 0 | 
| O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00022654 | 0 / 0 | 
| P21728 | D(1A) dopamine receptor | Dopamine receptor | C00030771 | 0 / 0 | 
| P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00030771 | 2 / 0 | 
| P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00030771 | 0 / 0 | 
| O60218 | Aldo-keto reductase family 1 member B10 | Enzyme | C00019064 | 0 / 0 | 
| P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00030771 | 0 / 0 | 
| P31645 | Sodium-dependent serotonin transporter | Serotonin | C00030771 | 2 / 0 | 
| P80404 | 4-aminobutyrate aminotransferase, mitochondrial | Transferase | C00002657 | 1 / 1 | 
| P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00030771 | 5 / 9 | 
| P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00030771 | 1 / 0 | 
| P21452 | Substance-K receptor | Neurokinin receptor | C00030771 | 0 / 0 | 
| P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00030771 | 0 / 0 | 
| P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00030771 | 3 / 0 | 
| P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00030771 | 0 / 0 | 
| Q96RI1 | Bile acid receptor | NR1H4 | C00019064 | 0 / 0 | 
| P18433 | Receptor-type tyrosine-protein phosphatase alpha | Receptor tyrosine-protein phosphatase | C00019064 | 0 / 0 | 
| P35236 | Tyrosine-protein phosphatase non-receptor type 7 | Tyr | C00019064 | 0 / 0 | 
| P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00030771 | 1 / 0 | 
| P28482 | Mitogen-activated protein kinase 1 | Erk | C00030771 | 0 / 0 | 
| P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00030771 | 2 / 1 | 
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00030771 | 0 / 0 | 
| Q16790 | Carbonic anhydrase 9 | Lyase | C00030771 | 0 / 1 | 
| P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | C00029547 | 0 / 0 | 
| Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00019064 | 0 / 0 | 
| O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00030771 | 0 / 0 | 
| P33765 | Adenosine receptor A3 | Adenosine receptor | C00030771 | 0 / 0 | 
| P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00030771 | 1 / 0 | 
| P22303 | Acetylcholinesterase | Hydrolase | C00030771 | 1 / 0 | 
| P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00030771 | 0 / 0 | 
| P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00030771 | 0 / 0 | 
| P35372 | Mu-type opioid receptor | Opioid receptor | C00030771 | 0 / 0 | 
| P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00030771 | 0 / 0 | 
| P25103 | Substance-P receptor | Neurokinin receptor | C00030771 | 0 / 0 | 
| P25105 | Platelet-activating factor receptor | PAF receptor | C00030771 | 0 / 0 | 
| P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00030771 | 0 / 0 | 
| P35228 | Nitric oxide synthase, inducible | Enzyme | C00019064 | 1 / 1 | 
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00030771 | 1 / 1 | 
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00030771 | 0 / 1 | 
| P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00030771 | 0 / 0 | 
| P04637 | Cellular tumor antigen p53 | Transcription Factor | C00030771 | 7 / 37 | 
| P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00019064 | 0 / 0 | 
| P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00030771 | 5 / 1 | 
| P19224 | UDP-glucuronosyltransferase 1-6 | Enzyme | C00030771 | 0 / 0 | 
| Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00030771 | 0 / 0 | 
| P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00030771 | 1 / 1 | 
| P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00030771 | 0 / 0 | 
| P30542 | Adenosine receptor A1 | Adenosine receptor | C00030771 | 0 / 0 | 
| P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00030771 | 0 / 0 | 
| P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00030771 | 1 / 1 | 
| P06239 | Tyrosine-protein kinase Lck | Src | C00030771 | 0 / 1 | 
| P17706 | Tyrosine-protein phosphatase non-receptor type 2 | Tyr | C00019064 | 0 / 1 | 
| P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00030771 | 0 / 0 | 
| P29350 | Tyrosine-protein phosphatase non-receptor type 6 | Tyr | C00019064 | 0 / 0 | 
| P04054 | Phospholipase A2 | Enzyme | C00019064 | 0 / 0 | 
| P23469 | Receptor-type tyrosine-protein phosphatase epsilon | Receptor tyrosine-protein phosphatase | C00019064 | 0 / 0 | 
| P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00029633 | 0 / 0 | 
| O00255 | Menin | Unclassified protein | C00022654 | 2 / 5 | 
| Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00022654 | 1 / 2 | 
| Q13951 | Core-binding factor subunit beta | Unclassified protein | C00019064 | 0 / 1 | 
| Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00019064 | 1 / 4 | 
| O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00030771 | 0 / 0 | 
| gene | gene name | gene description | KNApSAcK metabolite in interactions | 
|---|---|---|---|
| 5728 | PTEN, 10q23del, BZS, CWS1, DEC, GLM2, MHAM, MMAC1, PTEN1, TEP1 | phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48) | C00003749
                          C00019064 | 
| 1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) | C00019064 | 
| 1499 | CTNNB1, CTNNB, MRD19, armadillo | catenin (cadherin-associated protein), beta 1, 88kDa | C00003749 | 
| 6817 | SULT1A1, HAST1/HAST2, P-PST, PST, ST1A1, ST1A3, STP, STP1, TSPST1 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 (EC:2.8.2.1) | C00029547 | 
| 2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 | C00030771 | 
| 3952 | LEP, LEPD, OB, OBS | leptin | C00030771 | 
| 7031 | TFF1, BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2 | trefoil factor 1 | C00030771 | 
| 177 | AGER, RAGE | advanced glycosylation end product-specific receptor | C00019064 | 
| 836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | C00019064 | 
| 841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) | C00019064 | 
| 847 | CAT | catalase (EC:1.11.1.6) | C00019064 | 
| 595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 | C00019064 | 
| 1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) | C00019064 | 
| 6799 | SULT1A2, HAST4, P-PST, ST1A2, STP2, TSPST2 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2 (EC:2.8.2.1) | C00029547 | 
| 3065 | HDAC1, GON-10, HD1, RPD3, RPD3L1 | histone deacetylase 1 (EC:3.5.1.98) | C00019064 | 
| 3146 | HMGB1, HMG1, HMG3, SBP-1 | high mobility group box 1 | C00019064 | 
| 3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 | C00019064 | 
| 5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) | C00019064 | 
| 5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) | C00019064 | 
| 4233 | MET, AUTS9, HGFR, RCCP2, c-Met | met proto-oncogene (EC:2.7.10.1) | C00019064 | 
| 4780 | NFE2L2, NRF2 | nuclear factor, erythroid 2-like 2 | C00019064 | 
| 5052 | PRDX1, MSP23, NKEF-A, NKEFA, PAG, PAGA, PAGB, PRX1, PRXI, TDPX2 | peroxiredoxin 1 (EC:1.11.1.15) | C00019064 | 
| 6401 | SELE, CD62E, ELAM, ELAM1, ESEL, LECAM2 | selectin E | C00019064 | 
| 7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor | C00019064 | 
| 7150 | TOP1, TOPI | topoisomerase (DNA) I (EC:5.99.1.2) | C00019064 | 
| 7153 | TOP2A, TOP2, TP2A | topoisomerase (DNA) II alpha 170kDa (EC:5.99.1.3) | C00019064 | 
| 7412 | VCAM1, CD106, INCAM-100 | vascular cell adhesion molecule 1 | C00019064 | 
| OMIM | preferred title | UniProt | 
|---|---|---|
| #100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism | P20309 | 
| #202300 | Adrenocortical carcinoma, hereditary; adcc | P04637 | 
| #103780 | Alcohol dependence | P08172 P14416 P31645 | 
| #614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 | Q99720 | 
| #613546 | Aromatase deficiency | P11511 | 
| #139300 | Aromatase excess syndrome; aexs | P11511 | 
| #614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 | P04637 | 
| #601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 | P22309 | 
| #602025 | Body mass index quantitative trait locus 9; bmiq9 | P41968 | 
| #300615 | Brunner syndrome | P21397 | 
| #218800 | Crigler-najjar syndrome, type i | P22309 | 
| #606785 | Crigler-najjar syndrome, type ii | P22309 | 
| #162800 | Cyclic neutropenia | P08246 | 
| #612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 | P51681 | 
| #609535 | Drug metabolism, poor, cyp2c19-related | P33261 | 
| #608902 | Drug metabolism, poor, cyp2d6-related | P10635 | 
| #133239 | Esophageal cancer | P04637 | 
| #615363 | Estrogen resistance; estrr | P03372 | 
| #613163 | Gaba-transaminase deficiency | P80404 | 
| #613659 | Gastric cancer | P04626 | 
| #137215 | Gastric cancer, hereditary diffuse; hdgc | P04626 | 
| #231095 | Ghosal hematodiaphyseal dysplasia; ghdd | P24557 | 
| #143500 | Gilbert syndrome | P22309 | 
| #137800 | Glioma susceptibility 1; glm1 | P04626 | 
| #605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay | Q03164 | 
| #609423 | Human immunodeficiency virus type 1, susceptibility to | P41597 P51681 | 
| #237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn | P22309 | 
| #143860 | Hyperchlorhidrosis, isolated | O43570 | 
| #145000 | Hyperparathyroidism 1; hrpt1 | O00255 | 
| #603373 | Hyperthyroidism, familial gestational | P16473 | 
| #609152 | Hyperthyroidism, nonautoimmune | P16473 | 
| #275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 | P16473 | 
| #603932 | Intervertebral disc disease; idd | P14780 | 
| #607785 | Juvenile myelomonocytic leukemia; jmml | Q06124 | 
| #151100 | Leopard syndrome 1 | Q06124 | 
| #151623 | Li-fraumeni syndrome 1; lfs1 | P04637 | 
| #613688 | Long qt syndrome 2; lqt2 | Q12809 | 
| #211980 | Lung cancer | P00533 P04626 P04637 | 
| #608516 | Major depressive disorder; mdd | P08172 | 
| #611162 | Malaria, susceptibility to | P35228 | 
| %300852 | Mental retardation, x-linked 88; mrx88 | P50052 | 
| #156250 | Metachondromatosis; metcds | Q06124 | 
| #613073 | Metaphyseal anadysplasia 2; mandp2 | P14780 | 
| #131100 | Multiple endocrine neoplasia, type i; men1 | O00255 | 
| #126200 | Multiple sclerosis, susceptibility to; ms | P08575 | 
| #159900 | Myoclonic dystonia | P14416 | 
| #202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 | P08246 | 
| #163950 | Noonan syndrome 1; ns1 | Q06124 | 
| #601665 | Obesity | P32245 | 
| #164230 | Obsessive-compulsive disorder; ocd | P31645 | 
| #604715 | Orthostatic intolerance | P23975 | 
| #259730 | Osteopetrosis, autosomal recessive 3; optb3 | P00918 | 
| #167000 | Ovarian cancer | P04626 | 
| #260500 | Papilloma of choroid plexus; cpp | P04637 | 
| #613135 | Parkinsonism-dystonia, infantile; pkdys | Q01959 | 
| #601399 | Platelet disorder, familial, with associated myeloid malignancy | Q01196 | 
| #607276 | Resting heart rate, variation in | P08588 | 
| #608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive | P08575 | 
| #609620 | Short qt syndrome 1; sqt1 | Q12809 | 
| #275355 | Squamous cell carcinoma, head and neck; hnscc | P04637 | 
| #271980 | Succinic semialdehyde dehydrogenase deficiency; ssadhd | P51649 | 
| #190300 | Tremor, hereditary essential, 1; etm1 | P35462 | 
| #610379 | West nile virus, susceptibility to | P51681 | 
| #278300 | Xanthinuria, type i | P47989 | 
| #112100 | Yt blood group antigen | P22303 | 
| KEGG | name | UniProt | 
|---|---|---|
| H00033 | Adrenal carcinoma | O00255
                            (related) P04637 (related) | 
| H00034 | Carcinoid | O00255
                            (related) | 
| H00045 | Malignant islet cell carcinoma | O00255
                            (related) | 
| H00246 | Primary hyperparathyroidism | O00255
                            (related) | 
| H01102 | Pituitary adenomas | O00255
                            (related) | 
| H01302 | Hyperchlorhidrosis isolated (HCHLH) | O43570
                            (related) | 
| H00021 | Renal cell carcinoma | O43570
                            (marker) P04637 (marker) Q16790 (marker) | 
| H00016 | Oral cancer | P00533
                            (related) P00533 (marker) P04637 (related) P04637 (marker) | 
| H00017 | Esophageal cancer | P00533
                            (related) P04637 (related) P04637 (marker) P35228 (related) P35354 (related) | 
| H00018 | Gastric cancer | P00533
                            (related) P04626 (related) P04637 (related) | 
| H00022 | Bladder cancer | P00533
                            (related) P04626 (related) P04637 (related) | 
| H00028 | Choriocarcinoma | P00533
                            (related) P03956 (related) P04626 (related) P04637 (related) | 
| H00030 | Cervical cancer | P00533
                            (related) P04626 (related) | 
| H00042 | Glioma | P00533
                            (related) P00533 (marker) P04637 (related) P04637 (marker) | 
| H00055 | Laryngeal cancer | P00533
                            (related) P00533 (marker) P04637 (related) P04637 (marker) | 
| H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) | P00918
                            (related) | 
| H00436 | Osteopetrosis | P00918
                            (related) | 
| H00026 | Endometrial Cancer | P03372
                            (marker) P04626 (related) P04637 (related) Q92731 (marker) | 
| H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) | P04150
                            (related) P11511 (related) | 
| H00019 | Pancreatic cancer | P04626
                            (related) P04637 (related) P04637 (marker) | 
| H00027 | Ovarian cancer | P04626
                            (related) P04637 (related) | 
| H00031 | Breast cancer | P04626
                            (related) P04626 (marker) P04637 (related) | 
| H00046 | Cholangiocarcinoma | P04626
                            (related) P04637 (related) P35354 (related) | 
| H00004 | Chronic myeloid leukemia (CML) | P04637
                            (related) Q01196 (related) | 
| H00005 | Chronic lymphocytic leukemia (CLL) | P04637
                            (related) | 
| H00006 | Hairy-cell leukemia | P04637
                            (related) | 
| H00008 | Burkitt lymphoma | P04637
                            (related) | 
| H00009 | Adult T-cell leukemia | P04637
                            (related) | 
| H00010 | Multiple myeloma | P04637
                            (related) | 
| H00013 | Small cell lung cancer | P04637
                            (related) | 
| H00014 | Non-small cell lung cancer | P04637
                            (related) | 
| H00015 | Malignant pleural mesothelioma | P04637
                            (related) | 
| H00020 | Colorectal cancer | P04637
                            (related) P04637 (marker) | 
| H00025 | Penile cancer | P04637
                            (related) P04637 (marker) P14780 (related) P35354 (related) | 
| H00029 | Vulvar cancer | P04637
                            (related) | 
| H00032 | Thyroid cancer | P04637
                            (related) | 
| H00036 | Osteosarcoma | P04637
                            (related) P08684 (marker) | 
| H00038 | Malignant melanoma | P04637
                            (related) | 
| H00039 | Basal cell carcinoma | P04637
                            (related) | 
| H00040 | Squamous cell carcinoma | P04637
                            (related) | 
| H00041 | Kaposi's sarcoma | P04637
                            (related) | 
| H00044 | Cancer of the anal canal | P04637
                            (related) | 
| H00047 | Gallbladder cancer | P04637
                            (related) | 
| H00048 | Hepatocellular carcinoma | P04637
                            (related) | 
| H00881 | Li-Fraumeni syndrome | P04637
                            (related) | 
| H01007 | Choroid plexus papilloma | P04637
                            (related) | 
| H00093 | Combined immunodeficiencies (CIDs) | P06239
                            (related) | 
| H00079 | Asthma | P07550
                            (related) | 
| H00100 | Neutropenic disorders | P08246
                            (related) | 
| H00091 | T-B+Severe combined immunodeficiencies (SCIDs) | P08575
                            (related) | 
| H00794 | Aromatase excess syndrome | P11511
                            (related) | 
| H01205 | Coumarin resistance | P11712
                            (related) | 
| H00479 | Metaphyseal dysplasias | P14780
                            (related) | 
| H00250 | Congenital nongoitrous hypothyroidism (CHNG) | P16473
                            (related) | 
| H01269 | Congenital hyperthyroidism | P16473
                            (related) | 
| H00408 | Type I diabetes mellitus | P17706
                            (related) | 
| H00548 | Brunner syndrome | P21397
                            (related) | 
| H00208 | Hyperbilirubinemia | P22309
                            (related) | 
| H01031 | Orthostatic intolerance (OI) | P23975
                            (related) | 
| H00490 | Diaphyseal dysplasia with anemia (Ghosal) | P24557
                            (related) | 
| H01171 | Poor drug metabolism (PM) | P33261
                            (related) | 
| H00192 | Xanthinuria | P47989
                            (related) | 
| H00480 | Non-syndromic X-linked mental retardation | P50052
                            (related) | 
| H00835 | Succinic semialdehyde dehydrogenase (SSADH) deficiency | P51649
                            (related) | 
| H01257 | GABA-transaminase deficiency | P80404
                            (related) | 
| H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) | Q01196
                            (related) Q01196 (marker) Q03164 (related) Q03164 (marker) | 
| H00003 | Acute myeloid leukemia (AML) | Q01196
                            (related) Q01196 (marker) Q13951 (marker) | 
| H00978 | Thrombocytopenia (THC) | Q01196
                            (related) | 
| H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) | Q03164
                            (related) | 
| H00523 | Noonan syndrome and related disorders | Q06124
                            (related) | 
| H01018 | Metachondromatosis | Q06124
                            (related) | 
| H00720 | Long QT syndrome | Q12809
                            (related) | 
| H00725 | Short QT syndrome | Q12809
                            (related) | 
| MESH or OMIM | name | KNApSAcK metabolite | 
|---|---|---|
| D012878 | Skin Neoplasms | C00029547 C00003749 | 
| D050171 | Dyslipidemias | C00019064 | 
| D008113 | Liver Neoplasms | C00029547 | 
| D010212 | Papilloma | C00029547 | 
| D058739 | Aberrant Crypt Foci | C00029547 | 
| D006528 | Carcinoma, Hepatocellular | C00003749 | 
| D009202 | Cardiomyopathies | C00003749 | 
| D006937 | Hypercholesterolemia | C00003749 | 
| D009374 | Neoplasms, Experimental | C00003749 | 
| D014947 | Wounds and Injuries | C00003749 | 
| D002252 | Carbon Tetrachloride Poisoning | C00019064 | 
| D056486 | Drug-Induced Liver Injury | C00019064 | 
| D018248 | Adenoma, Liver Cell | C00029547 | 
| D018149 | Glucose Intolerance | C00019064 | 
| D006949 | Hyperlipidemias | C00019064 | 
| D007249 | Inflammation | C00019064 | 
| D007674 | Kidney Diseases | C00019064 | 
| D008103 | Liver Cirrhosis | C00019064 | 
| D008106 | Liver Cirrhosis, Experimental | C00019064 | 
| D008107 | Liver Diseases | C00019064 | 
| D017202 | Myocardial Ischemia | C00019064 | 
| D009369 | Neoplasms | C00019064 | 
| D009765 | Obesity | C00019064 | 
| D011041 | Poisoning | C00019064 | 
| D011230 | Precancerous Conditions | C00019064 |